Now you can take part of the Molecular Tumour Board Portal – decision support system for omics data in cancer treatment and clinical studies, webinar from december 12th. 2024. The Molecular Tumor Board Portal (MTBP) has been developed within Janne Lehtiö's lab at Karolinska Institutet and serves as a decision support system for patient inclusion in the Basket of Baskets (BoB) study, conducted as part of the Cancer Core Europe collaboration.

Welcome to a webinar about Molecular Tumour Board Portal – decision support system for omics data in cancer treatment and clinical studies. The Molecular Tumor Board Portal (MTBP) has been developed within Janne Lehtiö's lab at Karolinska Institutet and serves as a decision support system for patient inclusion in the Basket of Baskets (BoB) study, conducted as part of the Cancer Core Europe collaboration.

The report has been developed as a part of IHE’s partnership in the VINNOVA-funded innovation milieu Test Bed Sweden Precision Health Cancer.

Together with Lif - de forskande läkemedelsföretagen, Business Sweden, Embassy of Sweden in Madrid, Spain, we arranged for the second consecutive year a special evening event during the ESMO congress.

On April 23rd-24th, Vision Zero Cancer/ SIR will be at the Nordic Precision Medicine Forum in Stockholm and organise a workshop on impact assessment frameworks for Precision Medicine implementation.

The lung cancer policy network speaks to Ebba Hallersjö Hult, Co-founder and Head of Vision Zero Cancer, a mission-oriented innovation hub coordinated by Stockholm School of Economics Institute for Research, Sweden.

Folkhälsodalen (The Public Health Valley) is a meeting place for decision-makers, professionals, industry, and researchers in public health, medicine, and healthcare. An initiative of Reform Society. The seminars are in Swedish.

House of Innovation in collaboration with the Department of Accounting at Stockholm School of Economics orgianizes two Workshops on Measuring Impact of Mission Driven Innovation Collaborations during this fall.

A Public-Private Partnership focusing on implementation of precision health in cancer in Sweden is under establishment. SweConnect will be project managed by Vision Zero Cancer in collaboration with Genomic Medicine Sweden (GMS).

Combining Expertise Across Borders to Promote Precision Cancer Medicine in Europe. PRIME-ROSE is a Horizon Europe Mission on Cancer project with 24 partners from altogether 18 European countries. Moreover, PRIME-ROSE is part of the Cancer Mission cluster of projects on Diagnosis and Treatment.

Folkhälsodalen (The Public Health Valley) is a meeting place for decision-makers, professionals, industry, and researchers in public health, medicine, and healthcare. An initiative of Reform Society. The seminars are in Swedish.

In 2021, Vision Zero Cancer, Genomic Medicine Sweden (GMS) and SciLifeLab joined forces with public sector authorities, regions, healthcare, academia, industry and patient associations to create an innovation hub that facilitates the introduction of more precise prevention and treatment in cancer care.